- Home
- IBTA vs CRON Comparison
IBTA vs CRON Comparison
Compare IBTA & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBTA
- CRON
- Stock Information
- Founded
- IBTA 2011
- CRON N/A
- Country
- IBTA United States
- CRON Canada
- Employees
- IBTA N/A
- CRON N/A
- Industry
- IBTA
- CRON Medicinal Chemicals and Botanical Products
- Sector
- IBTA
- CRON Health Care
- Exchange
- IBTA Nasdaq
- CRON Nasdaq
- Market Cap
- IBTA 926.1M
- CRON 961.2M
- IPO Year
- IBTA 2024
- CRON N/A
- Fundamental
- Price
- IBTA $31.39
- CRON $2.54
- Analyst Decision
- IBTA Hold
- CRON
- Analyst Count
- IBTA 10
- CRON 0
- Target Price
- IBTA $43.89
- CRON N/A
- AVG Volume (30 Days)
- IBTA 266.9K
- CRON 1.6M
- Earning Date
- IBTA 11-12-2025
- CRON 11-06-2025
- Dividend Yield
- IBTA N/A
- CRON N/A
- EPS Growth
- IBTA 2512.20
- CRON N/A
- EPS
- IBTA 2.84
- CRON 0.05
- Revenue
- IBTA $367,604,000.00
- CRON $130,282,000.00
- Revenue This Year
- IBTA N/A
- CRON $19.67
- Revenue Next Year
- IBTA $0.58
- CRON $30.56
- P/E Ratio
- IBTA $11.36
- CRON $52.65
- Revenue Growth
- IBTA 3.49
- CRON 28.01
- 52 Week Low
- IBTA $22.50
- CRON $1.60
- 52 Week High
- IBTA $79.80
- CRON $3.16
- Technical
- Relative Strength Index (RSI)
- IBTA 48.25
- CRON 52.24
- Support Level
- IBTA $32.06
- CRON $2.44
- Resistance Level
- IBTA $35.23
- CRON $2.53
- Average True Range (ATR)
- IBTA 1.28
- CRON 0.09
- MACD
- IBTA -0.19
- CRON -0.00
- Stochastic Oscillator
- IBTA 38.46
- CRON 46.30
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.